Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Gross Margin (2018 - 2025)

Historic Gross Margin for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to 57.49%.

  • Viemed Healthcare's Gross Margin fell 17600.0% to 57.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.89%, marking a year-over-year decrease of 23900.0%. This contributed to the annual value of 59.4% for FY2024, which is 22300.0% down from last year.
  • Per Viemed Healthcare's latest filing, its Gross Margin stood at 57.49% for Q3 2025, which was down 17600.0% from 58.25% recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Gross Margin registered a high of 64.33% during Q2 2021, and its lowest value of 56.28% during Q1 2025.
  • For the 5-year period, Viemed Healthcare's Gross Margin averaged around 60.57%, with its median value being 60.68% (2023).
  • Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 46100bps in 2021, then tumbled by -37500bps in 2024.
  • Over the past 5 years, Viemed Healthcare's Gross Margin (Quarter) stood at 61.52% in 2021, then fell by -1bps to 61.04% in 2022, then rose by 4bps to 63.29% in 2023, then dropped by -6bps to 59.54% in 2024, then dropped by -3bps to 57.49% in 2025.
  • Its Gross Margin was 57.49% in Q3 2025, compared to 58.25% in Q2 2025 and 56.28% in Q1 2025.